Treace Medical Concepts, Inc.

NasdaqGS:TMCI Stok Raporu

Piyasa değeri: US$487.8m

Treace Medical Concepts Yönetim

Yönetim kriter kontrolleri 2/4

Treace Medical Concepts CEO'su John Treace, Jul2014 tarihinde atandı, in görev süresi 10.33 yıldır. in toplam yıllık tazminatı $ 8.42M olup, şirket hissesi ve opsiyonları dahil olmak üzere 8.1% maaş ve 91.9% ikramiyelerden oluşmaktadır. şirketin hisselerinin 18.7% ine doğrudan sahiptir ve bu hisseler $ 91.23M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.2 yıl ve 6.8 yıldır.

Anahtar bilgiler

John Treace

İcra Kurulu Başkanı

US$8.4m

Toplam tazminat

CEO maaş yüzdesi8.1%
CEO görev süresi10.3yrs
CEO sahipliği18.7%
Yönetim ortalama görev süresi3.2yrs
Yönetim Kurulu ortalama görev süresi6.8yrs

Son yönetim güncellemeleri

Recent updates

Is Treace Medical Concepts (NASDAQ:TMCI) Using Debt In A Risky Way?

Oct 26
Is Treace Medical Concepts (NASDAQ:TMCI) Using Debt In A Risky Way?

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Screens Well But There Might Be A Catch

Aug 02
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Screens Well But There Might Be A Catch

Treace Medical Concepts (NASDAQ:TMCI) Has Debt But No Earnings; Should You Worry?

Jun 28
Treace Medical Concepts (NASDAQ:TMCI) Has Debt But No Earnings; Should You Worry?

Treace Medical Concepts: Facing Increasing Competitive Pressure

Jun 14

Market Still Lacking Some Conviction On Treace Medical Concepts, Inc. (NASDAQ:TMCI)

Apr 05
Market Still Lacking Some Conviction On Treace Medical Concepts, Inc. (NASDAQ:TMCI)

Does Treace Medical Concepts (NASDAQ:TMCI) Have A Healthy Balance Sheet?

Feb 09
Does Treace Medical Concepts (NASDAQ:TMCI) Have A Healthy Balance Sheet?

Why Investors Shouldn't Be Surprised By Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) 31% Share Price Surge

Jan 04
Why Investors Shouldn't Be Surprised By Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) 31% Share Price Surge

Market Cool On Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Revenues Pushing Shares 46% Lower

Nov 11
Market Cool On Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Revenues Pushing Shares 46% Lower

Analysts Are Updating Their Treace Medical Concepts, Inc. (NASDAQ:TMCI) Estimates After Its Second-Quarter Results

Aug 13
Analysts Are Updating Their Treace Medical Concepts, Inc. (NASDAQ:TMCI) Estimates After Its Second-Quarter Results

CEO Tazminat Analizi

John Treace'un ücretlendirmesi Treace Medical Concepts'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

-US$62m

Jun 30 2024n/an/a

-US$64m

Mar 31 2024n/an/a

-US$55m

Dec 31 2023US$8mUS$684k

-US$50m

Sep 30 2023n/an/a

-US$48m

Jun 30 2023n/an/a

-US$42m

Mar 31 2023n/an/a

-US$47m

Dec 31 2022US$4mUS$568k

-US$43m

Sep 30 2022n/an/a

-US$45m

Jun 30 2022n/an/a

-US$39m

Mar 31 2022n/an/a

-US$27m

Dec 31 2021US$688kUS$410k

-US$21m

Sep 30 2021n/an/a

-US$12m

Jun 30 2021n/an/a

-US$8m

Mar 31 2021n/an/a

-US$5m

Dec 31 2020US$392kUS$316k

-US$4m

Tazminat ve Piyasa: John 'nin toplam tazminatı ($USD 8.42M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 2.14M ).

Tazminat ve Kazançlar: John şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

John Treace (52 yo)

10.3yrs

Görev süresi

US$8,422,635

Tazminat

Mr. John T. Treace Founded Treace Medical Concepts, Inc. in 2014 and has been its Chief Executive Officer and Director since July 1, 2014. Before that, Mr. Treace served as Senior Vice President of U.S. Sa...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
John Treace
CEO, Founder & Director10.3yrsUS$8.42m18.7%
$ 91.2m
Mark Hair
Chief Financial Officer4.2yrsUS$4.69m0.031%
$ 151.5k
Aaron Berutti
Senior Vice President of Sales3.3yrsUS$3.26m0.0066%
$ 32.0k
Terry Lubben
Chief Operations & Supply Chain Officer3.2yrsVeri yokVeri yok
Taylor Erickson
Chief Information Officer2.7yrsVeri yokVeri yok
Scot Elder
Chief Legal & Compliance Officer and Corporate Secretary3.1yrsVeri yok0.050%
$ 242.5k
Nathan Minnich
Senior Vice President of Marketing1.3yrsVeri yokVeri yok
Daniel Owens
Chief Human Resources Officer3.8yrsVeri yok0.0084%
$ 41.2k
Sean Scanlan
Chief Innovation Officer1.8yrsVeri yok0.056%
$ 273.2k
Shana Zink
Senior Vice President of Clinical Affairs & Reimbursementno dataVeri yokVeri yok
Rachel Osbeck
Senior Vice President of Quality Assurance & Regulatory Affairsno dataVeri yokVeri yok

3.2yrs

Ortalama Görev Süresi

52yo

Ortalama Yaş

Deneyimli Yönetim: TMCI 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.2 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
John Treace
CEO, Founder & Director10.3yrsUS$8.42m18.7%
$ 91.2m
Lawrence Hamilton
Independent Director4yrsUS$214.79k0.0081%
$ 39.5k
James Treace
Chairman of the Board10.4yrsUS$94.74k2.86%
$ 13.9m
Richard Mott
Independent Director9.7yrsUS$197.26k1.7%
$ 8.3m
John Bakewell
Independent Director4yrsUS$214.79k0.77%
$ 3.7m
Deepti Jain
Independent Director3.1yrsUS$209.79k0.050%
$ 241.5k
Paul Dayton
Member of the Surgeon Advisory Boardno dataVeri yokVeri yok
William DeCarbo
Member of the Surgeon Advisory Boardno dataVeri yokVeri yok
Daniel Hatch
Member of the Surgeon Advisory Boardno dataVeri yokVeri yok
J.P. McAleer
Member of the Surgeon Advisory Boardno dataVeri yokVeri yok
W. Smith
Member of the Surgeon Advisory Boardno dataVeri yokVeri yok
Robert Santrock
Member of the Surgeon Advisory Boardno dataVeri yokVeri yok

6.8yrs

Ortalama Görev Süresi

63.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: TMCI 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.8 yıldır).